Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: cardiometabolic implications

OBJECTIVE: Early-stage breast cancer (BC) is the second most common malignancy in women, worldwide. Early-detection and treatment advances have led to 5-year survival rates of 90% for early-stage breast cancer. However, the long-term morbidity of breast cancer remains high, with a majority of surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyon, Debra E., Yao, Yingwei, Garrett, Timothy, Kelly, Debra Lynch, Cousin, Lakeshia, Archer, Kellie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158001/
https://www.ncbi.nlm.nih.gov/pubmed/37138260
http://dx.doi.org/10.1186/s12905-023-02355-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158001/
https://www.ncbi.nlm.nih.gov/pubmed/37138260
http://dx.doi.org/10.1186/s12905-023-02355-7

Ejemplares similares